Ligand validation:5BN6

GAL: beta-D-galactopyranose

GAL is a Ligand Of Interest in 5BN6 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5BN6_GAL_E_200	81%	62%	0.095	0.946	0.6	0.84	-	-	1	0	100%	0.9575
5BN6_GAL_F_1200	69%	64%	0.109	0.922	0.49	0.86	-	-	1	0	100%	0.9617
5BN6_GAL_H_2200	59%	68%	0.119	0.901	0.43	0.79	-	-	1	0	100%	0.9608
5BN6_GAL_G_3200	54%	68%	0.115	0.879	0.51	0.68	-	-	1	0	100%	1
4R6P_GAL_G_202	45%	13%	0.137	0.867	1.66	2.48	4	5	0	0	100%	1
5ELB_GAL_C_202	100%	57%	0.036	0.992	0.82	0.8	-	-	0	0	100%	0.6
4WWH_GAL_B_401	100%	61%	0.047	0.993	0.51	0.97	-	1	0	0	100%	1
3OGR_GAL_A_1024	99%	47%	0.053	0.987	0.79	1.26	-	1	1	0	100%	1
1NSX_GAL_B_2400	98%	50%	0.055	0.981	0.56	1.36	-	3	0	0	100%	1
2EUK_GAL_A_300	98%	59%	0.053	0.973	0.56	0.97	-	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.